{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:51:50Z","timestamp":1774468310608,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL159156 and HL170224."],"award-info":[{"award-number":["HL159156 and HL170224."]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03210-2","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:27:40Z","timestamp":1768231660000},"page":"261-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oxidized phospholipids on plasminogen are associated with reduced platelet surface marker expression and intrinsic reactivity"],"prefix":"10.1007","volume":"59","author":[{"given":"Alexander","family":"Kille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"N\u00fchrenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kilian","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Valina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Leibundgut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willibald","family":"Hochholzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"3210_CR1","first-page":"2639","volume-title":"And sibbing D: international consensus statement on platelet function and genetic testing in percutaneous coronary intervention: 2024 update","author":"DJ Angiolillo","year":"2024","unstructured":"Angiolillo DJ, Galli M, Alexopoulos D, Aradi D, Bhatt DL, Bonello L, Capodanno D, Cavallari LH, Collet J-P, Cuisset T, Ferreiro JL, Franchi F, Geisler T, Gibson CM, Gorog DA, Gurbel PA, Jeong Y-H, Marcucci R, Siller-Matula JM, Mehran R, Neumann F-J, Pereira NL, Rizas KD, Rollini F, So DYF, Stone GW, Storey RF, Tantry US, Berg JT, Trenk D, Valgimigli M, Waksman R (2024) And sibbing D: international consensus statement on platelet function and genetic testing in percutaneous coronary intervention: 2024 update, vol 17. Cardiovascular Interventions, JACC, pp 2639\u20132663"},{"key":"3210_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-0042-1757898","volume":"49","author":"JB Larsen","year":"2023","unstructured":"Larsen JB, Hvas AM, Hojbjerg JA (2023) Platelet function testing: update and future directions. Semin Thromb Hemost 49:600\u2013608","journal-title":"Semin Thromb Hemost"},{"key":"3210_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","volume":"16","author":"PEJ van der Meijden","year":"2019","unstructured":"van der Meijden PEJ, Heemskerk JWM (2019) Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol 16:166\u2013179","journal-title":"Nat Rev Cardiol"},{"key":"3210_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1152\/physrev.00020.2015","volume":"96","author":"EM Bevers","year":"2016","unstructured":"Bevers EM, Williamson PL (2016) Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol Rev 96:605\u2013645","journal-title":"Physiol Rev"},{"key":"3210_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1089\/ars.2009.2597","volume":"12","author":"VN Bochkov","year":"2010","unstructured":"Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stockl J (2010) Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12:1009\u20131059","journal-title":"Antioxid Redox Signal"},{"key":"3210_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-023-00937-4","volume":"21","author":"S Tsimikas","year":"2024","unstructured":"Tsimikas S, Witztum JL (2024) Oxidized phospholipids in cardiovascular disease. Nat Rev Cardiol 21:170\u2013191","journal-title":"Nat Rev Cardiol"},{"key":"3210_CR7","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","volume":"49","author":"C Bergmark","year":"2008","unstructured":"Bergmark C, Dewan A, Orsoni A, Merki E, Miller ER, Shin MJ, Binder CJ, Horkko S, Krauss RM, Chapman MJ, Witztum JL, Tsimikas S (2008) A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 49:2230\u20132239","journal-title":"J Lipid Res"},{"key":"3210_CR8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jacc.2011.12.033","volume":"59","author":"G Leibundgut","year":"2012","unstructured":"Leibundgut G, Arai K, Orsoni A, Yin H, Scipione C, Miller ER, Koschinsky ML, Chapman MJ, Witztum JL, Tsimikas S (2012) Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction. J Am Coll Cardiol 59:1426\u20131437","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR9","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1194\/jlr.M040733","volume":"54","author":"G Leibundgut","year":"2013","unstructured":"Leibundgut G, Scipione C, Yin H, Schneider M, Boffa MB, Green S, Yang X, Dennis E, Witztum JL, Koschinsky ML, Tsimikas S (2013) Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J Lipid Res 54:2815\u20132830","journal-title":"J Lipid Res"},{"key":"3210_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11239-015-1292-5","volume":"42","author":"AP DeFilippis","year":"2016","unstructured":"DeFilippis AP, Chernyavskiy I, Amraotkar AR, Trainor PJ, Kothari S, Ismail I, Hargis CW, Korley FK, Leibundgut G, Tsimikas S, Rai SN, Bhatnagar A (2016) Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction. J Thromb Thrombolysis 42:61\u201376","journal-title":"J Thromb Thrombolysis"},{"key":"3210_CR11","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/eurheartj\/ehab600","volume":"43","author":"AP DeFilippis","year":"2022","unstructured":"DeFilippis AP, Trainor PJ, Thanassoulis G, Brumback LC, Post WS, Tsai MY, Tsimikas S (2022) Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis. Eur Heart J 43:971\u2013981","journal-title":"Eur Heart J"},{"key":"3210_CR12","doi-asserted-by":"publisher","first-page":"117451","DOI":"10.1016\/j.atherosclerosis.2024.117451","volume":"390","author":"KCF Lidani","year":"2024","unstructured":"Lidani KCF, Trainor PJ, Bhatia HS, Nasir K, Blaha MJ, Tsai MY, Gottesman RF, Post WS, Thanassoulis G, Tsimikas S (2024) Heckbert SR and defilippis AP: atherothrombotic and thrombolytic biomarkers in incident stroke and atrial fibrillation-related stroke: the Multi-Ethnic study of atherosclerosis (MESA). Atherosclerosis 390:117451","journal-title":"Atherosclerosis"},{"key":"3210_CR13","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","volume":"48","author":"W Hochholzer","year":"2006","unstructured":"Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, Gick M, Caputo A, Buttner HJ, Neumann FJ (2006) Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 48:1742\u20131750","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1161\/01.CIR.0000160869.75810.98","volume":"111","author":"W Hochholzer","year":"2005","unstructured":"Hochholzer W, Trenk D, Frundi D, Blanke P, Fischer B, Andris K, Bestehorn HP, Buttner HJ, Neumann FJ (2005) Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation 111:2560\u20132564","journal-title":"Circulation"},{"key":"3210_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.thromres.2006.02.007","volume":"119","author":"W Hochholzer","year":"2007","unstructured":"Hochholzer W, Trenk D, Frundi D, Neumann FJ (2007) Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel. Thromb Res 119:285\u2013291","journal-title":"Thromb Res"},{"key":"3210_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12265-018-9790-4","volume":"11","author":"H Kothari","year":"2018","unstructured":"Kothari H, Nguyen AT, Yang X, Hisada Y, Tsimikas S, Mackman N, Taylor A, McNamara CA (2018) Association of D-dimer with plaque characteristics and plasma biomarkers of oxidation-specific epitopes in stable subjects with coronary artery disease. J Cardiovasc Transl Res 11:221\u2013229","journal-title":"J Cardiovasc Transl Res"},{"key":"3210_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2022.06.1020","volume":"354","author":"R Clarke","year":"2022","unstructured":"Clarke R, Hammami I, Sherliker P, Valdes-Marquez E, Watkins H, Hill M, Yang X, Tsimikas S, Hopewell JC, Consortium P (2022) Oxidized phospholipids on Apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study. Atherosclerosis 354:15\u201322","journal-title":"Atherosclerosis"},{"key":"3210_CR18","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1016\/j.jacc.2013.02.047","volume":"61","author":"ML Bertoia","year":"2013","unstructured":"Bertoia ML, Pai JK, Lee JH, Taleb A, Joosten MM, Mittleman MA, Yang X, Witztum JL, Rimm EB, Tsimikas S, Mukamal KJ (2013) Oxidation-specific biomarkers and risk of peripheral artery disease. J Am Coll Cardiol 61:2169\u20132179","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR19","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.jacc.2023.02.050","volume":"81","author":"TC Gilliland","year":"2023","unstructured":"Gilliland TC, Liu Y, Mohebi R, Miksenas H, Haidermota S, Wong M, Hu X, Cristino JR, Browne A, Plutzky J, Tsimikas S, Januzzi JL (2023) Jr. and Natarajan P: Lipoprotein(a), oxidized Phospholipids, and coronary artery disease severity and outcomes. J Am Coll Cardiol 81:1780\u20131792","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","volume":"47","author":"S Tsimikas","year":"2006","unstructured":"Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F, Witztum JL (2006) Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J Am Coll Cardiol 47:2219\u20132228","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/S0266462301104034","volume":"17","author":"FE Harrell Jr.","year":"2001","unstructured":"Harrell FE Jr., Shih YC (2001) Using full probability models to compute probabilities of actual interest to decision makers. Int J Technol Assess Health Care 17:17\u201326","journal-title":"Int J Technol Assess Health Care"},{"key":"3210_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0519-5","volume":"18","author":"W Chen","year":"2018","unstructured":"Chen W, Qian L, Shi J, Franklin M (2018) Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Med Res Methodol 18:63","journal-title":"BMC Med Res Methodol"},{"key":"3210_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-3-21","volume":"3","author":"AJ Barros","year":"2003","unstructured":"Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3:21","journal-title":"BMC Med Res Methodol"},{"key":"3210_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0735-1097(02)02769-9","volume":"41","author":"S Tsimikas","year":"2003","unstructured":"Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41:360\u2013370","journal-title":"J Am Coll Cardiol"},{"key":"3210_CR25","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.3390\/ijms11125339","volume":"11","author":"C Edelstein","year":"2010","unstructured":"Edelstein C, Pfaffinger D, Reichert EC, Stafforini DM, Scanu AM (2010) Mouse plasminogen has oxidized phosphatidylcholine adducts that are not metabolized by Lipoprotein-Associated phospholipase A(2) under basal conditions. Int J Mol Sci 11:5339\u20135347","journal-title":"Int J Mol Sci"},{"key":"3210_CR26","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bbalip.2010.03.009","volume":"1801","author":"C Edelstein","year":"2010","unstructured":"Edelstein C, Pfaffinger D, Yang M, Hill JS, Scanu AM (2010) Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts. Biochim Biophys Acta 1801:738\u2013745","journal-title":"Biochim Biophys Acta"},{"key":"3210_CR27","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm1626","volume":"13","author":"EA Podrez","year":"2007","unstructured":"Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL (2007) Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13:1086\u20131095","journal-title":"Nat Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03210-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:22:57Z","timestamp":1774426977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3210"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03210-2","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Tsimikas is a coinventor and has received royalties from patents owned by the University of California-San Diego; is a co-founder of and has an equity interest in Oxitope and Kleanthi Diagnostics and has a dual appointment at the University of California San Diego and Ionis Pharmaceuticals. Dr. Kille reports speaker honoraria from Sysmex Astra Zeneca. Prof. Franz-Josef Neumann reports that his institution has received research grants, consultancy fees, and speaker honoraria from Daiichi Sankyo, Astra Zeneca, Sanofi-Aventis, Bayer, The Medicines Company, Bristol, Novartis, Roche, Boston Scientific, Biotronik, Medtronic, Edwards, and Ferrer. Prof. Hochholzer received consultancy honoraria from Daiichi Sankyo, The Medicines Company, and Ferrer and reports speaker honoraria from AstraZeneca, Bayer Vital, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, and feo GmbH as well as research grants paid to his former institution from German Heart Foundation, Novartis, and Sysmex. Dr. N\u00fchrenberg is an employee of Novartis as of October 2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}